Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Letter from the Editor
I was talking to Ashley Ball, PharmD Candidate, LECOM-School of Pharmacy, about the problem with helping patients with DPN. We were talking about how you can definitively say the pain is really DPN, and not something else like arthritis.
She decided to see what kind of tests were available and how effective they are. Unlike glucose monitors, CGM devices, or even blood pressure monitors, there is no definitive device that clinicians can use.
She did put together a great feature on what is available and how you can take advantage of these tests for your patient.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
Newsflash: US Preventive Services Task Force Issues New Screening Recommendation
The US Preventive Services Task Force released a final recommendation statement, published in the Journal of the American Medical Association, calling for prediabetes and type 2 diabetes screening for asymptomatic adults starting at 35 years of age for those that are overweight.
TOP STORIES — Diabetes News and Research
Does early-onset type 2 diabetes put young patients at a higher risk of developing comorbidities as they become adults?
There is not much evidence-based literature on point-of-care devices, yet they are commonly used for diagnosis.
Can a new potential treatment combining an SGLT-2 and a GLP-1 RA mitigate cardiometabolic risk?
Did You Know? The Effects of Long-Term Drinking of Coffee:
The object of the study was to evaluate the long-term consequences of coffee drinking in patients with T2D and how it affects the risk of mortality from all-cause, CVD, and CHD. The researchers included ten prospective cohort studies with 82,270 cases. They found that compared to those with no coffee consumption, the HRs for 4 cups were 0.79, for all-cause mortality, 0,60, for CVD mortality, 0.68, for coronary heart disease (CHD) mortality, 0.72 for CHD, and 0.77 for total CVD events. Thus, the researchers concluded that “Drinking coffee can be inversely associated with the risk of mortality in patients with T2D.” Nutrition, Metabolism & Cardiovascular Diseases (2021) 31, 2526-2538
Diabetes in Control gratefully acknowledges the assistance of the following pharmacy doctoral candidates in the preparation of this week’s newsletters:
Ashley Ball, PharmD Candidate, LECOM-School of Pharmacy
Andy Dao, PharmD Candidate, University of South Florida Taneja College of Pharmacy
Jasmine Dumontier-Hiott, PharmD Candidate 2022, University of South Florida Taneja College of Pharmacy
Jerrine Fletcher, Doctor of Pharmacy Candidate, Florida A&M University College of Pharmacy and Pharmaceutical Sciences
Oluwatayo Ishola, PharmD. Candidate, South College, School of Pharmacy
Brenda Oppong, PharmD Candidate, LECOM School of Pharmacy
Your Friends in Diabetes Care
Steve and Dave
Diabetes In Control
www.diabetesincontrol.com